Maitreya Medicare (NSE:MAITREYA) Cash Flow from Financing: ₹-9.6 Mil (TTM As of Sep. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MAITREYA Maitreya Medicare Ltd NSE:MAITREYA
18 GF Score
Price ₹122.00
View Full Analysis

What is Maitreya Medicare Cash Flow from Financing?

Maitreya Medicare NSE:MAITREYA -1.73% 18 Cash Flow from Financing is ₹-9.6 Mil as of Sep. 2023. GuruFocus rates NSE:MAITREYA with a GF Score™ of 18/100.

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Sep. 2023, Maitreya Medicare paid ₹0.0 Mil more to buy back shares than it received from issuing new shares. It spent ₹6.5 Mil paying down its debt. It paid ₹0.0 Mil more to buy back preferred shares than it received from issuing preferred shares. It received ₹0.0 Mil from paying cash dividends to shareholders. It spent ₹3.1 Mil on other financial activities. In all, Maitreya Medicare spent ₹9.6 Mil on financial activities for the six months ended in Sep. 2023.


Maitreya Medicare  (NSE:MAITREYA) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Maitreya Medicare's issuance of stock for the six months ended in Sep. 2023 was ₹0.0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Maitreya Medicare's repurchase of stock for the six months ended in Sep. 2023 was ₹0.0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Maitreya Medicare's net issuance of debt for the six months ended in Sep. 2023 was ₹-6.5 Mil. Maitreya Medicare spent ₹6.5 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Maitreya Medicare's net issuance of preferred for the six months ended in Sep. 2023 was ₹0.0 Mil. Maitreya Medicare paid ₹0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Maitreya Medicare's cash flow for dividends for the six months ended in Sep. 2023 was ₹0.0 Mil. Maitreya Medicare received ₹0.0 Mil from paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Maitreya Medicare's other financing for the six months ended in Sep. 2023 was ₹-3.1 Mil. Maitreya Medicare spent ₹3.1 Mil on other financial activities.


Maitreya Medicare Cash Flow from Financing Related Terms


Maitreya Medicare Cash Flow from Financing Historical Data

* Premium members only.

The historical data trend for Maitreya Medicare's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maitreya Medicare Cash Flow from Financing Chart

Maitreya Medicare Annual Data
Trend Mar21 Mar22 Mar23
Cash Flow from Financing
21.63 -18.63 -16.11

Maitreya Medicare Semi-Annual Data
Mar21 Mar22 Mar23 Sep23
Cash Flow from Financing 0.00 0.00 0.00 -9.63
NSE:MAITREYA
18GF Score
Maitreya Medicare Ltd NSE:MAITREYA
Cash Flow from Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Maitreya Medicare Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Maitreya Medicare's Cash from Financing for the fiscal year that ended in Mar. 2023 is calculated as:

Maitreya Medicare's Cash from Financing for the quarter that ended in Sep. 2023 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹-9.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow from Financing of ₹-9.6 Mil mean?
Maitreya Medicare (NSE:MAITREYA) has a Cash Flow from Financing of ₹-9.6 Mil as of Sep. 2023. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Maitreya Medicare and its competitors.
Is Maitreya Medicare's Cash Flow from Financing too high?
Maitreya Medicare's current Cash Flow from Financing is ₹-9.6 Mil. Overall, Maitreya Medicare has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Maitreya Medicare's Cash Flow from Financing compare to HCA and DVA?
Maitreya Medicare's Cash Flow from Financing of ₹-9.6 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow from Financing for a Healthcare Providers & Services company?
A good Cash Flow from Financing depends on the Healthcare Providers & Services industry context. However, Cash Flow from Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow from Financing mean?
A high Cash Flow from Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow from Financing is the amount of cash earned or paid from financing operations. View historical data for Maitreya Medicare and its competitors. Maitreya Medicare's current Cash Flow from Financing is ₹-9.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maitreya Medicare stock overvalued right now?
Maitreya Medicare (NSE:MAITREYA) has a current Cash Flow from Financing of ₹-9.6 Mil. The current Cash Flow from Financing is ₹-9.6 Mil. Maitreya Medicare's overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow from Financing calculated?
Cash Flow from Financing is calculated from a company's financial statements. For Maitreya Medicare (NSE:MAITREYA), the current Cash Flow from Financing is ₹-9.6 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Maitreya Medicare Business Description

Address Nr. Someshwara Char Rasta, Udhana - Magdalla Road, Surat, GJ, IND, 395007
Maitreya Medicare Ltd is Multi Superspeciality hospital. It is a 125 bedded hospital that provides multi-disciplinary integrated healthcare services, with a focus on primary secondary & tertiary care, and also offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Oncology, Laparoscopic Surgery, Neurology, Neurosurgery, Spine Surgery, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine etc.
18GF Score

Get the complete analysis for NSE:MAITREYA

Cash Flow from Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹122.00
Price